BLOMSTEIN Handles two Foreign Direct Investment Procedures for GTCR

BLOMSTEIN has successfully handled two Foreign Direct Investment procedures for GTCR, a leading private equity firm. GTCR has acquired the assets of the TachoSil Fibrin Sealant Patch, a sponge for hemostasis and wound sealing, and the Surgical Specialties Corporation (SSC), which is specialized in high performance surgical sutures and ophthalmic knives. Subsequently, the investor merged SSC and Tachosil into a leading provider of surgical medical products and created the new company Corza Medical.